Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Conradt

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
HNO|September 24, 2002
[Occupational hazardous substance exposure and nutrition. Risk factors for mouth, pharyngeal and laryngeal carcinomas?]H Maier, M Tisch, H Kyrberg, et al.
European Journal of Anaesthesiology|April 2, 1999
Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind studyS Chrubasik, H Junck, H Breitschwerdt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1997
In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancerV Rudat, A Dietz, C Conradt, et al.
HNO|October 20, 1999
[p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas]F X Bosch, N Homann, C Conradt, et al.
HNO|April 20, 2002
[Orbital floor reconstruction. Comparison of a new perforated 0.15 mm thick PDS layer with established titanium dynamic mesh]A Dacho, H Steffen, C M Ziegler, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 6, 2002
Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hipS Chrubasik, J Thanner, O Künzel, et al.
Environmental Health Perspectives|March 27, 2001
Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodiesV Daniel, W Huber, K Bauer, et al.
The American Journal of Medicine|August 11, 2000
Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyS Chrubasik, E Eisenberg, E Balan, et al.
Head & Neck|September 26, 2000
Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapyA Dietz, V Rudat, C Conradt, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 2000
Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapyB Vanselow, M J Eble, V Rudat, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
HNO|September 24, 2002
[Occupational hazardous substance exposure and nutrition. Risk factors for mouth, pharyngeal and laryngeal carcinomas?]H Maier, M Tisch, H Kyrberg, et al.
European Journal of Anaesthesiology|April 2, 1999
Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebo-controlled, double-blind studyS Chrubasik, H Junck, H Breitschwerdt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 1, 1997
In vitro radiosensitivity of primary human fibroblasts. Lack of correlation with acute radiation toxicity in patients with head and neck cancerV Rudat, A Dietz, C Conradt, et al.
HNO|October 20, 1999
[p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas]F X Bosch, N Homann, C Conradt, et al.
HNO|April 20, 2002
[Orbital floor reconstruction. Comparison of a new perforated 0.15 mm thick PDS layer with established titanium dynamic mesh]A Dacho, H Steffen, C M Ziegler, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 6, 2002
Comparison of outcome measures during treatment with the proprietary Harpagophytum extract doloteffin in patients with pain in the lower back, knee or hipS Chrubasik, J Thanner, O Künzel, et al.
Environmental Health Perspectives|March 27, 2001
Associations of blood levels of PCB, HCHS, and HCB with numbers of lymphocyte subpopulations, in vitro lymphocyte response, plasma cytokine levels, and immunoglobulin autoantibodiesV Daniel, W Huber, K Bauer, et al.
The American Journal of Medicine|August 11, 2000
Treatment of low back pain exacerbations with willow bark extract: a randomized double-blind studyS Chrubasik, E Eisenberg, E Balan, et al.
Head & Neck|September 26, 2000
Prognostic relevance of serum levels of the angiogenic peptide bFGF in advanced carcinoma of the head and neck treated by primary radiochemotherapyA Dietz, V Rudat, C Conradt, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 1, 2000
Oxygenation of advanced head and neck cancer: prognostic marker for the response to primary radiochemotherapyB Vanselow, M J Eble, V Rudat, et al.
Pageof 6